| 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 |
---|
Net Income From Continuing Operations | 1,351 | 917 | 1,023 |
---|
Depreciation | 92 | 96 | 120 |
---|
Amortization | 103 | 116 | 116 |
---|
Impairment of assets | 7 | 9 | - |
---|
Research and Development in Process | 104 | 107 | - |
---|
Acquired in-process research and development and milestones | - | - | 8 |
---|
Deferred income taxes | -288 | -18 | -485 |
---|
Stock-based compensation | 59 | 75 | 101 |
---|
Unrealized foreign exchange loss (gain) | - | 18 | -40 |
---|
Other | -12 | -26 | -31 |
---|
Accounts receivable | 277 | 123 | 212 |
---|
Inventories | 138 | 220 | 230 |
---|
Other current assets | -353 | 43 | 10 |
---|
Trade accounts payable | 663 | -237 | 163 |
---|
Accrued and other current liabilities | 329 | 172 | 102 |
---|
Due from/due to related party | -164 | - | - |
---|
Income taxes payable | -119 | 7 | 16 |
---|
Other | -55 | 8 | -16 |
---|
Net Cash Flows Provided by Operating Activities from Continuing Operations | 2,160 | 858 | 799 |
---|
Capital expenditures | 192 | 196 | 251 |
---|
Proceeds from sale of property, plant and equipment | 7 | 7 | 1 |
---|
Acquired in-process research and development and milestones | 104 | 107 | 8 |
---|
Purchase of product rights and asset acquisition, net of cash acquired | 192 | 124 | 2 |
---|
Net Cash Flows Used in Investing Activities from Continuing Operations | -481 | -420 | -260 |
---|
Proceeds from debt | 9,470 | - | 80 |
---|
Repayments of debt | 112 | 108 | 338 |
---|
Payment of long-term debt issuance costs | 118 | - | - |
---|
Repayments of short-term borrowings from Merck & Co., Inc., net | 1,512 | - | - |
---|
Repayments of short-term borrowings from Merck & Co., Inc., net | 1,512 | - | - |
---|
Net consideration paid to Merck & Co. Inc. in connection with the Separation | 9,000 | - | - |
---|
Net consideration paid to Merck & Co. Inc. in connection with the Separation | 9,000 | - | - |
---|
Net transfers to Merck & Co., Inc. | -440 | 24 | - |
---|
Net transfers to Merck & Co., Inc. | -440 | 24 | - |
---|
Employee withholding taxes related to stock-based awards | - | 11 | 17 |
---|
Employee withholding taxes related to stock-based awards | - | 11 | 17 |
---|
Dividend payments | 145 | 290 | 294 |
---|
Dividend payments | 145 | 290 | 294 |
---|
Net Cash Flows Used in Financing Activities from Continuing Operations | -977 | -433 | -569 |
---|
Net Cash Flows Used in Financing Activities from Continuing Operations | -977 | -433 | -569 |
---|
Net Cash Provided by (Used in) Operating Activities | 298 | - | - |
---|
Net Cash Used in Financing Activities | -356 | - | - |
---|
Net Cash Used in Financing Activities | -356 | - | - |
---|
Net Cash Flows Used in Discontinued Operations | -58 | - | - |
---|
Net Cash Flows Used in Discontinued Operations | -58 | - | - |
---|
Effect of Exchange Rate Changes on Cash and Cash Equivalents from Continuing Operations | 23 | -36 | 17 |
---|
Net (Decrease) Increase in Cash and Cash Equivalents | 667 | -31 | -13 |
---|
Net (Decrease) Increase in Cash and Cash Equivalents | 667 | -31 | -13 |
---|